- Home
- J&J Innovative Medicine
J&J Innovative Medicine
“We want a world without tuberculosis in our lifetimes”
Healthcare providers who contracted TB on the job. A microbiologist researching new treatments. An activist ensuring attention is paid to one of the world’s greatest health threats. These young leaders share one goal: to help end TB.
What you need to know about Johnson & Johnson’s 2021 fourth-quarter and full-year earnings report
Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Consumer Health, Pharmaceutical and Medical Devices businesses.
4 things to know about the flu in the time of COVID-19
How can you tell which virus is causing your cough or fever? Is it too late to get a flu shot if you haven’t? A Johnson & Johnson expert addresses these questions—and how the company is working to improve the future of flu prevention.
4 things to know about RSV in the time of COVID-19
Respiratory syncytial virus (RSV) is normally rampant in winter—but the pandemic has changed the behavior of this common and potentially dangerous infection. For National RSV Awareness Month, learn how Johnson & Johnson is working to keep us all safer from RSV.
This ring may just help protect women against HIV
As the International AIDS Conference kicks off, learn how a new tool will help give this group greater power to prevent HIV on a monthly basis.
Johnson & Johnson COVID-19 vaccine named one of Time‘s Best Inventions of 2021.
The vaccine is one of three COVID-19 vaccines sharing joint recognition on the list of groundbreaking innovations this year.
“I want to live a life that’s not defined by my schizophrenia”
For World Schizophrenia Day, learn about how one inspiring young man with the condition is thriving despite the challenges—and how Johnson & Johnson is helping him and others like him to find new ways to manage their mental illness.
What you need to know about Johnson & Johnson’s 2021 third-quarter earnings
Check out this infographic breakdown of the company’s third-quarter 2021 performance, with key highlights from its Pharmaceutical, Consumer Health and Medical Devices businesses.
Curing cancer from within: The promise of cell therapy
Harnessing the immune system to target cancer is the goal of a groundbreaking area of oncology research called cell therapy. And Johnson & Johnson is hard at work in the cutting-edge field, aiming to deliver potential new treatment options to people around the world.
How your own DNA could someday save your vision
Imagine living with a genetic disease that could cause blindness in your 40s—and your doctor tells you there are no treatment options. It’s for patients like these that Johnson & Johnson is harnessing cutting-edge technology in the hope of finding real solutions.